These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

446 related items for PubMed ID: 26232865

  • 21. Pilot of BRAF mutation analysis in indeterminate, suspicious and malignant thyroid FNA cytology.
    Johnson SJ, Hardy SA, Roberts C, Bourn D, Mallick U, Perros P.
    Cytopathology; 2014 Jun; 25(3):146-54. PubMed ID: 24417615
    [Abstract] [Full Text] [Related]

  • 22. Significance of BRAF V600E Mutation and Cytomorphological Features for the Optimization of Papillary Thyroid Cancer Diagnostics in Cytologically Indeterminate Thyroid Nodules.
    Beiša A, Kvietkauskas M, Beiša V, Stoškus M, Ostanevičiūtė E, Jasiūnas E, Griškevičius L, Šeinin D, Šileikytė A, Strupas K.
    Exp Clin Endocrinol Diabetes; 2019 Apr; 127(4):247-254. PubMed ID: 29566402
    [Abstract] [Full Text] [Related]

  • 23. Prediction Table and Nomogram as Tools for Diagnosis of Papillary Thyroid Carcinoma: Combined Analysis of Ultrasonography, Fine-Needle Aspiration Biopsy, and BRAF V600E Mutation.
    Kim SK, Lee JH, Woo JW, Park I, Choe JH, Kim JH, Kim JS.
    Medicine (Baltimore); 2015 May; 94(21):e760. PubMed ID: 26020381
    [Abstract] [Full Text] [Related]

  • 24. Effect of BRAF V600E mutation detection of fine-needle aspiration biopsy on diagnosis and treatment guidance of papillary thyroid carcinoma.
    Qi W, Shi C, Zhang P, Feng L, Wang J, Chen D.
    Pathol Res Pract; 2020 Aug; 216(8):153037. PubMed ID: 32703500
    [Abstract] [Full Text] [Related]

  • 25. Diagnostic value of B-RAF(V600E) in difficult-to-diagnose thyroid nodules using fine-needle aspiration: systematic review and meta-analysis.
    Jia Y, Yu Y, Li X, Wei S, Zheng X, Yang X, Zhao J, Xia T, Gao M.
    Diagn Cytopathol; 2014 Jan; 42(1):94-101. PubMed ID: 24167125
    [Abstract] [Full Text] [Related]

  • 26. Detection of BRAFV600E mutation on fine needle aspiration specimens of thyroid nodule refines cyto-pathology diagnosis, especially in BRAF600E mutation-prevalent area.
    Chung KW, Yang SK, Lee GK, Kim EY, Kwon S, Lee SH, Park DJ, Lee HS, Cho BY, Lee ES, Kim SW.
    Clin Endocrinol (Oxf); 2006 Nov; 65(5):660-6. PubMed ID: 17054470
    [Abstract] [Full Text] [Related]

  • 27. BRAFV600E mutation test on fine-needle aspiration specimens of thyroid nodules: Clinical correlations for 4600 patients.
    Chen H, Song A, Wang Y, He Y, Tong J, Di J, Li C, Zhou Z, Cai X, Zhong D, Da J.
    Cancer Med; 2022 Jan; 11(1):40-49. PubMed ID: 34851044
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Mutant-specific BRAF and CD117 immunocytochemistry potentially facilitate risk stratification for papillary thyroid carcinoma in fine-needle aspiration biopsy specimens.
    Meng Z, Lu J, Wu H, Zhao Y, Luo Y, Gao J, Zhu Q, Jiang Y, Li W, Liang Z.
    Tumour Biol; 2016 Jan; 37(1):611-8. PubMed ID: 26240026
    [Abstract] [Full Text] [Related]

  • 30. Detection of BRAF V600E mutation in fine-needle aspiration fluid of papillary thyroid carcinoma by droplet digital PCR.
    Xu X, Ma X, Zhang X, Cao G, Tang Y, Deng X, Kang Z, Li M, Guan M.
    Clin Chim Acta; 2019 Apr; 491():91-96. PubMed ID: 30682328
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. The BRAF(V600E) mutation is associated with malignant ultrasonographic features in thyroid nodules.
    Lee EJ, Song KH, Kim DL, Jang YM, Hwang TS, Kim SK.
    Clin Endocrinol (Oxf); 2011 Dec; 75(6):844-50. PubMed ID: 21707687
    [Abstract] [Full Text] [Related]

  • 34. [The predictive accuracy of fine needle aspiration and BRAF V600E mutation in diagnosis of papillary thyroid carcinoma].
    Yu X, Wang Y, Xie QP, Yan HC, Zhao QZ, Zhang ML, Xiang C, Wang P.
    Zhonghua Wai Ke Za Zhi; 2019 Apr 01; 57(4):305-308. PubMed ID: 30929378
    [Abstract] [Full Text] [Related]

  • 35. Circulating BRAFV600E in the diagnosis and follow-up of differentiated papillary thyroid carcinoma.
    Pupilli C, Pinzani P, Salvianti F, Fibbi B, Rossi M, Petrone L, Perigli G, De Feo ML, Vezzosi V, Pazzagli M, Orlando C, Forti G.
    J Clin Endocrinol Metab; 2013 Aug 01; 98(8):3359-65. PubMed ID: 23788690
    [Abstract] [Full Text] [Related]

  • 36. [Correlation between Ultrasound-guided Fine-needle Aspiration Combined with BRAF V600EDetection and Invasive Pathological Features of Papillary Thyroid Cancer].
    Zhang Y, Luo YK, Zhang Y, Zhang MB, Guang Y, Xie F, Jiang B, Tang J.
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2019 Aug 30; 41(4):517-523. PubMed ID: 31484615
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. BRAFV600E mutation as a predictor of thyroid malignancy in indeterminate nodules: A systematic review and meta-analysis.
    Jinih M, Foley N, Osho O, Houlihan L, Toor AA, Khan JZ, Achakzai AA, Redmond HP.
    Eur J Surg Oncol; 2017 Jul 30; 43(7):1219-1227. PubMed ID: 27923591
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Value of BRAF V600E in High-Risk Thyroid Nodules with Benign Cytology Results.
    Chen X, Zhou Q, Wang F, Zhang F, Du H, Zhang Q, Wu W, Gong X.
    AJNR Am J Neuroradiol; 2018 Dec 30; 39(12):2360-2365. PubMed ID: 30498021
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 23.